GlaxoSmithKline Pharmaceuticals Statistics

Total Valuation

GlaxoSmithKline Pharmaceuticals has a market cap or net worth of INR 387.01 billion. The enterprise value is 366.05 billion.

Market Cap	387.01B
Enterprise Value	366.05B

Important Dates

The next estimated earnings date is Thursday, February 6, 2025.

Earnings Date	Feb 6, 2025
Ex-Dividend Date	Nov 7, 2024

Share Statistics

GlaxoSmithKline Pharmaceuticals has 169.41 million shares outstanding. The number of shares has decreased by -1.89% in one year.

Current Share Class	n/a
Shares Outstanding	169.41M
Shares Change (YoY)	-1.89%
Shares Change (QoQ)	+1.57%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	6.32%
Float	41.29M

Valuation Ratios

The trailing PE ratio is 57.33 and the forward PE ratio is 42.15.

PE Ratio	57.33
Forward PE	42.15
PS Ratio	10.87
PB Ratio	23.51
P/TBV Ratio	23.39
P/FCF Ratio	41.17
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 35.99, with an EV/FCF ratio of 38.94.

EV / Earnings	54.23
EV / Sales	10.28
EV / EBITDA	35.99
EV / EBIT	38.17
EV / FCF	38.94

Financial Position

The company has a current ratio of 1.66, with a Debt / Equity ratio of 0.01.

Current Ratio	1.66
Quick Ratio	1.31
Debt / Equity	0.01
Debt / EBITDA	0.01
Debt / FCF	0.02
Interest Coverage	554.80

Financial Efficiency

Return on equity (ROE) is 42.03% and return on invested capital (ROIC) is 36.91%.

Return on Equity (ROE)	42.03%
Return on Assets (ROA)	17.09%
Return on Capital (ROIC)	36.91%
Revenue Per Employee	11.09M
Profits Per Employee	2.10M
Employee Count	3,211
Asset Turnover	1.01
Inventory Turnover	2.62

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +33.38% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+33.38%
50-Day Moving Average	2,501.22
200-Day Moving Average	2,466.14
Relative Strength Index (RSI)	37.91
Average Volume (20 Days)	3,221

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, GlaxoSmithKline Pharmaceuticals had revenue of INR 35.60 billion and earned 6.75 billion in profits. Earnings per share was 39.84.

Revenue	35.60B
Gross Profit	21.76B
Operating Income	9.59B
Pretax Income	9.29B
Net Income	6.75B
EBITDA	9.99B
EBIT	9.59B
Earnings Per Share (EPS)	39.84

Full Income Statement

Balance Sheet

The company has 21.11 billion in cash and 147.90 million in debt, giving a net cash position of 20.96 billion or 123.73 per share.

Cash & Cash Equivalents	21.11B
Total Debt	147.90M
Net Cash	20.96B
Net Cash Per Share	123.73
Equity (Book Value)	16.73B
Book Value Per Share	97.18
Working Capital	12.01B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 9.71 billion and capital expenditures -312.22 million, giving a free cash flow of 9.40 billion.

Operating Cash Flow	9.71B
Capital Expenditures	-312.22M
Free Cash Flow	9.40B
FCF Per Share	55.49

Full Cash Flow Statement

Margins

Gross margin is 61.12%, with operating and profit margins of 26.94% and 18.96%.

Gross Margin	61.12%
Operating Margin	26.94%
Pretax Margin	26.10%
Profit Margin	18.96%
EBITDA Margin	28.07%
EBIT Margin	26.94%
FCF Margin	26.40%

Dividends & Yields

This stock pays an annual dividend of 32.00, which amounts to a dividend yield of 1.40%.

Dividend Per Share	32.00
Dividend Yield	1.40%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	80.23%
Buyback Yield	1.89%
Shareholder Yield	3.29%
Earnings Yield	1.74%
FCF Yield	2.43%

Dividend Details

Stock Splits

The last stock split was on September 11, 2018. It was a forward split with a ratio of 2.

Last Split Date	Sep 11, 2018
Split Type	Forward
Split Ratio	2

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a